BiotechTube
Home/Nymox Pharmaceutical/Paul Averback
PA

Paul Averback

Founder

Nymox Pharmaceutical

Therapeutic Areas

UrologyOncology

Nymox Pharmaceutical Pipeline

DrugIndicationPhase
Fexapotide Triflutate (NX-1207)Benign Prostatic Hyperplasia (BPH)Phase 3

Leadership Team at Nymox Pharmaceutical

NS
Neal Shore
Key Clinical Investigator (from publications)
RT
Ronald Tutrone
Key Clinical Investigator (from publications)
CG
Claus G. Roehrborn
Key Clinical Investigator (from publications)
View full Nymox Pharmaceutical profile